[LGND] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
01-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- 867.48%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 186,419 120,282 251,453 141,102 108,973 71,914 64,538 19.31%
PBT -10,538 796,639 173,330 57,231 7,960 35,329 11,302 -
Tax -7,553 167,337 30,009 44,675 10,327 -219,596 410 -
NP -2,985 629,302 143,321 12,556 -1,636 257,305 12,024 -
Tax Rate - -21.01% -17.31% -78.06% -129.74% 621.57% -3.63% -
Total Cost 189,404 -509,020 108,132 128,546 110,609 -185,391 52,514 23.81%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -1.60 523.19 57.00 8.90 -1.50 357.80 18.63 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.18 33.13 5.96 0.60 -0.08 13.00 0.59 -
EPS Diluted -0.18 31.85 5.96 0.53 -0.08 12.12 0.56 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.